Anuh Pharma Limited (NSE:ANUHPHR)
India flag India · Delayed Price · Currency is INR
81.94
-0.22 (-0.27%)
Nov 6, 2026, 3:29 PM IST

Anuh Pharma Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
477.7410.46473.52600.58361.8305.61
Depreciation & Amortization
107.85112.7786.4284.8796.49119.02
Other Amortization
1.051.050.980.970.510.57
Loss (Gain) From Sale of Assets
-0.1-0.94-0.17--0.15-0.62
Asset Writedown & Restructuring Costs
0.08-0.010.22--
Loss (Gain) From Sale of Investments
-18.22-26.84-68.88-107.21-43.39-26.37
Provision & Write-off of Bad Debts
0.9----2-0.51
Other Operating Activities
40.2922.4910.24-14.35-37.92-16.19
Change in Accounts Receivable
438.31-199.45-271.16-187.47-354.96-287.96
Change in Inventory
-542.43-732.749.19-27.6472.8715.03
Change in Accounts Payable
-162.55239.69177.04-125.87322.2215.58
Change in Other Net Operating Assets
161.82143.4-45.94-94.84123.53164.47
Operating Cash Flow
504.7-30.12371.25129.25539.02288.64
Operating Cash Flow Growth
314.11%-187.23%-76.02%86.75%-

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-53.97-78.69-201.46-50.17-15.5-16.15
Sale of Property, Plant & Equipment
0.210.99--0.571.43
Investment in Securities
-423.74250.67-12.1447.87-438.14-86.59
Other Investing Activities
6.885.4414.5111.4818.2423.14
Investing Cash Flow
-470.62178.42-199.099.18-434.84-78.17

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
--84.8520.13--
Total Debt Issued
194.76-84.8520.13--
Short-Term Debt Repaid
--104.98---31.11-104.87
Long-Term Debt Repaid
--3.54-3.46-3.08-3.08-3.35
Lease Payments
-3.25-3.54-3.46-3.08-3.08-3.35
Total Debt Repaid
-3.25-108.52-3.46-3.08-34.19-108.22
Net Debt Issued (Repaid)
191.51-108.5281.3817.06-34.19-108.22
Common Dividends Paid
-147.99-149.7-125.22-100.25-87.48-75.58
Other Financing Activities
-3.02-5.06-4.76-2.49-1.2-10.7
Financing Cash Flow
40.51-263.28-48.6-85.68-122.87-194.49

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Cash Flow
74.59-114.98123.5652.75-18.6915.97

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
450.74-108.8169.7979.09523.52272.49
Free Cash Flow Growth
--114.69%-84.89%92.12%-
Free Cash Flow Margin
5.80%-1.41%2.57%1.22%9.93%5.60%
Free Cash Flow Per Share
4.50-1.093.390.795.222.72
Levered Free Cash Flow
373.12-218.75133.71125.18479.05254.68
Unlevered Free Cash Flow
374.62-215.8137.58127.39480.42260.69
Free Cash Flow After Leases
447.49-112.34166.3376.01520.44269.14

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
5.065.064.762.491.210.69
Cash Income Tax Paid
132.43132.43111.22190.7134.6791.38
Change in Working Capital
-104.85-549.11-130.86-435.81163.67-92.89